Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ginecologia Y Obstetricia De Mexico|January 6, 2016
[Symptomatic exaggerated placental site after first trimester abortion]Nayara López-Carpintero, Jesús de la Fuente-Valero, Francisco Javier Salazar-Arquero, et al.
Cancers|June 24, 2022
Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with GliomasSantiago Cabezas-Camarero, Vanesa García-Barberán, Rebeca Pérez-Alfayate, et al.
Neuro-Oncology Advances|August 30, 2024
Durable benefit and slowdown in tumor growth dynamics with erdafitinib in a FGFR3-TACC3 fusion-positive IDH-wild type glioblastomaSantiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Carmen Polidura, et al.
The Oncologist|March 4, 2024
Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With VismodegibSantiago Cabezas-Camarero, Vanesa García-Barberán, Rebeca Pérez-Alfayate, et al.
Frontiers in Neurology|October 13, 2025
Somatic mutations in angiogenesis-related pathways and RNA polymerase II activity in sporadic brain arteriovenous malformationsRebeca Pérez-Alfayate, Vanesa García-Barberán, Isabel Casado-Fariñas, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 26, 2023
Histopathologic Changes in Congenital Corneal Stromal Dystrophy: Report of 4 Cases in 2 FamiliesAna M Colino Gallardo, Montserrat De la Torre Serrano, Lorenzo Alarcón García, et al.
Neuro-Oncology Advances|April 28, 2026
Rapid and profound radiological and plasma ctDNA responses to dabrafenib plus trametinib in BRAF-mutant papillary craniopharyngiomaSantiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Vanesa García-Barberán, et al.
Therapeutic Advances in Medical Oncology|June 13, 2022
Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated gliomaSantiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Vanesa García-Barberán, et al.
Pageof 1